US Bancorp
BNTC icon

US Bancorp’s Benitec Biopharma BNTC Stock Holding History

US Bancorp’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26K Sell
94
-388
-80% -$4.6K ﹤0.01% 3944
2026
Q1 		$5.13K Buy
482
+280
+139% +$3.24K ﹤0.01% 3561
2025
Q4 		$2.72K Buy
+202
New +$2.79K ﹤0.01% 3699

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

US Bancorp's BNTC Position: Q2 2026 in Review

US Bancorp reduced its Benitec Biopharma (BNTC) stake by 80% in Q2 2026, selling an estimated $4.6K and leaving 94 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3944.

US Bancorp first reported a position in BNTC in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.13K in Q1 2026. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • US Bancorp held 94 shares of Benitec Biopharma worth $1.26K as of Q2 2026.
  • US Bancorp sold 388 Benitec Biopharma shares in Q2 2026, an estimated $4.6K.
  • Benitec Biopharma made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3944 holding.
  • US Bancorp first reported a position in Benitec Biopharma in Q4 2025 and has held it in 3 quarters since.
  • US Bancorp's Benitec Biopharma position peaked at $5.13K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.